Tempest Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-11.2M | $-12.0M | $849.0K | $1.4M |
| FY2013 | $-18.1M | $-18.8M | $719.0K | $5.1M |
| FY2014 | $-30.6M | $-33.4M | $2.8M | $12.4M |
| FY2015 | $-50.3M | $-55.5M | $5.2M | $19.3M |
| FY2016 | $-61.7M | $-64.3M | $2.6M | $9.2M |
| FY2017 | $-20.3M | $-20.3M | $4.0K | $6.9M |
| FY2018 | $-23.6M | $-23.7M | $36.0K | — |
| FY2019 | $-41.2M | $-41.6M | $397.0K | — |
| FY2020 | $-19.0M | $-19.1M | $50.0K | — |
| FY2021 | $-26.0M | $-26.1M | $135.0K | — |
| FY2022 | $-31.1M | $-31.6M | $562.0K | — |
| FY2023 | $-27.4M | $-27.5M | $170.0K | — |
| FY2024 | $-33.0M | $-33.5M | $435.0K | — |
| FY2025 | $-26.8M | $-26.8M | $0 | — |